Table: Daito - 9-MTH group results

Daito Pharmaceutical

14/04/2021 07:00

Apr 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 28, 2021        Feb 29, 2020     May 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               37.84               34.37            48.90    
                   (+10.1 pct)         (+13.1 pct)      (+8.7 pct)  
  Operating            5.34                4.58             5.90    
                   (+16.4 pct)         (+25.1 pct)      (+10.1 pct) 
  Recurring            5.42                4.64             6.00    
                   (+16.8 pct)         (+23.7 pct)      (+9.8 pct)  
  Net                  3.70                3.24             4.00    
                   (+14.2 pct)         (+27.1 pct)      (+1.4 pct)  
  EPS              271.39 yen          256.48 yen       297.60 yen  
  EPS Diluted                          254.98 yen                   
  Ann Div                               46.00 yen        46.00 yen  
  -Q2 div           23.00 yen           20.00 yen                   
  -Q4 div                               26.00 yen        23.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T